Data-Driven Methods for Advancing Precision Oncology.

Area of Science:

• Biomedical Research
• Oncology
• Data Science

Background:

• Precision oncology tailors cancer treatment using genetic, clinical, environmental, and lifestyle data.
• Challenges include managing voluminous, heterogeneous data from diverse sources like Omics and electronic health records.
• Statistical and machine learning methods are crucial for handling complex, large-scale biomedical data.

Purpose of the Study:

• To review advances, methods, challenges, and future directions of data-driven approaches in precision oncology.
• To highlight the role of data analytics in biomedical research, drug discovery, and clinical practice.
• To discuss the integration of diverse data modalities for personalized cancer care.

Main Methods:

• Review of data-driven methods, including statistical and machine learning algorithms.
• Analysis of challenges in handling heterogeneous data from Omics, EHRs, imaging, and wearables.
• Exploration of predictive modeling for cancer progression, drug response, and treatment optimization.

Main Results:

• Data-driven analytics have accelerated biomarker discovery and drug development in precision oncology.
• Predictive models aid in identifying patient populations, forecasting cancer progression, and optimizing combination therapies.
• Machine learning and open Omics datasets are key drivers of precision oncology advancements.

Conclusions:

• Integrated clinical decision support systems combining EHR and Omics data are essential for data-driven recommendations.
• These systems will assist clinicians in disease prevention, early detection, and personalized cancer treatment.
• Continuous updates to clinical decision systems are necessary to adapt to evolving cancer knowledge and datasets.